本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Intellia Therapeutics Inc

8.48
-0.2200-2.53%
盘后8.41-0.0697-0.82%19:55 EST
成交量:609.11万
成交额:5,178.21万
市值:9.82亿
市盈率:-1.99
高:8.81
开:8.56
低:8.23
收:8.70
52周最高:28.25
52周最低:5.90
股本:1.16亿
流通股本:1.02亿
量比:0.69
换手率:5.97%
股息:- -
股息率:- -
每股收益(TTM):-4.2519
每股收益(LYR):-5.2506
净资产收益率:-52.11%
总资产收益率:-28.51%
市净率:1.31
市盈率(LYR):-1.62

数据加载中...

2020/02/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2019/12/16

重要事件披露

Current report, item 8.01
2019/10/31

重要事件披露

Current report, items 2.02 and 9.01
2019/10/31

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/09/26

重要事件披露

Current report, item 8.01
2019/09/10

SEC问询函

[Cover]Correspondence
2019/09/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/30

SEC问询函

[Cover]Correspondence
2019/08/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/01

季度报告

Quarterly report [Sections 13 or 15(d)]